EDGAR·FLOW

ROCKWELL MEDICAL, INC. — Form 10-Q

Filed November 12, 2026 · analyzed by the Periodic Agent
10-Q ▲ Likely positive significance 92/100
What the filing says
Vantive Limited (Seller) agreed to sell equity interests in HD Group Entities and related assets to Rockwell Medical, Inc. (Buyer) in a transaction dated November 2, 2026. Buyer will pay closing consideration via cash, Buyer Senior Facilities (term loans), and a Buyer Convertible Note, with earnout payments up to $45M based on EBITDA and revenue milestones over 8 years. Transaction includes deferred local business closings in certain jurisdictions pending approvals; some French assets excluded pending employee consultation.
Why this rating

For $28.7M-cap Rockwell, acquiring a standalone dialysis business with earnout potential of $45M (~157% of current market cap) is transformational. Creates material revenue/EBITDA base and acquisition currency via convertible note. Materially alters company trajectory.

Tradability signal
NO TRADE

No trade: positive news with only +0.6% moved so far — good news prices in within seconds and long-side continuation has shown no measured edge (this cell: -0.74% over 4 hrs, n=27). (Filing arrived outside market hours — evaluated at the next open with a live quote.)

Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.

Price action (we called it positive)
at our read · unknown
$7.15
+10 min · unknown
$7.10 ▼ 0.70%
+30 min · unknown
$6.99 ▼ 2.24%
+1 hr · unknown
$6.99 ▼ 2.24%
+4 hrs · unknown
$7.53 ▲ 5.31%

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ RMTI · stock on Yahoo Finance ↗

See more from November 12, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.